BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report.
BRCA1/2
HGSOC
NGS
PARPi
molecular pathology
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
28 11 2021
28 11 2021
Historique:
received:
16
11
2021
revised:
22
11
2021
accepted:
23
11
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
17
2
2022
Statut:
epublish
Résumé
High-grade serous ovarian carcinoma (HGSOC) is the most common subtype of all ovarian carcinomas. HGSOC harboring
Identifiants
pubmed: 34946865
pii: genes12121917
doi: 10.3390/genes12121917
pmc: PMC8702012
pii:
doi:
Substances chimiques
BRCA1 Protein
0
BRCA1 protein, human
0
BRCA2 Protein
0
BRCA2 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Ann Oncol. 2019 May 1;30(5):672-705
pubmed: 31046081
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
J Clin Oncol. 2020 Apr 10;38(11):1222-1245
pubmed: 31986064
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
J Clin Pathol. 2021 Oct;74(10):668-672
pubmed: 33020174
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Cancers (Basel). 2021 Jan 04;13(1):
pubmed: 33406752
Am J Pathol. 2016 Apr;186(4):733-47
pubmed: 27012190
Int J Gynaecol Obstet. 2014 Jan;124(1):1-5
pubmed: 24219974
Br J Cancer. 2017 Mar 14;116(6):802-810
pubmed: 28170370
Nat Commun. 2017 Oct 23;8(1):1093
pubmed: 29061967
N Engl J Med. 2019 Dec 19;381(25):2391-2402
pubmed: 31562799
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
Int J Mol Sci. 2021 Apr 19;22(8):
pubmed: 33921561
Lancet Oncol. 2017 Jan;18(1):75-87
pubmed: 27908594
Int J Mol Sci. 2019 Feb 22;20(4):
pubmed: 30813239
Crit Rev Oncol Hematol. 2019 Aug;140:67-72
pubmed: 31176273
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884